Gene signature found for poor response to standard chemotherapy in rare uterine cancer

(Medical College of Georgia at Augusta University) Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome.